Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.64EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.68EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.65 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.466EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
L.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.339EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.229EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.415EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.370EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.421EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.428.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.612EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.305EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.1.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.11.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HC.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.53 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.599EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.128EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.451EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.313EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.402EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.609EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.344EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.556EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.245EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.403EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.636EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.126EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.47EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDQ.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.31.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FD.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GN.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FW.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.1.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBLEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EK.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used